Literature DB >> 12847393

Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion.

Takashi Masuda1, Kiyotaka Sato, Chiharu Noda, Kazuko M Ikeda, Atsuhiko Matsunaga, Misao N Ogura, Kazuhiko Shimizu, Hiroshi Nagasawa, Narihisa Matsuyama, Tohru Izumi.   

Abstract

OBJECTIVE: To examine the mitochondrial function in the myocardium after hemorrhagic shock and reperfusion and to evaluate the protective effect of urinary trypsin inhibitor (UTI) on mitochondria.
DESIGN: Animal experiment.
SETTING: University research laboratory.
SUBJECTS: Wistar rats receiving 50,000 units/kg/hr of UTI (n = 27; UTI group) and control rats (n = 26; control group).
INTERVENTIONS: Rats were subjected to low-perfusion ischemia with the left ventricular systolic pressure maintained at 50 mm Hg for 60 mins by bleeding, followed by a 60-min reperfusion by transfusion of shed blood. UTI was infused continuously from 10 mins before bleeding. Cardiac function was measured before bleeding, after bleeding, and after transfusion; at each determination point, the myocardial contents of adenosine triphosphate (ATP), creatine phosphate (P-Cr), pyruvate (Pyr), and lactate (Lac) were measured enzymatically. The cytosolic phosphorylation potential (PP) as well as the redox potential of the oxidized form of nicotinamide adenine dinucleotide/reduced form of nicotinamide adenine dinucleotide couple in mitochondria (Eh(NAD+/NADH)) and change of Gibbs free energy in ATP hydrolysis (deltaG(ATP hydrolysis) energy) were calculated.
MEASUREMENTS AND MAIN RESULTS: Cardiac function decreased during hemorrhagic shock but improved significantly in the UTI group after transfusion compared with the control group. Lac and the Lac/Pyr ratio were significantly lower in the UTI group than in the control group after transfusion. ATP and P-Cr were significantly higher in the UTI group than in the control group after transfusion. PP (x10(3) M-1), Eh(NAD+/NADH) (x - 1 mV), and deltaG(ATP hydrolysis) (x - 1 kcal/mol) were 1.9 +/- 0.4, 266 +/- 4, and 9.7 +/- 0.2, respectively, in the control group and 4.0 +/- 0.9, 274 +/- 5 and 13.0 +/- 0.2, respectively, in the UTI group after transfusion (p <.001, p <.001, and p <.001, respectively).
CONCLUSIONS: In reperfusion after hemorrhagic shock, oxidative phosphorylation in myocardial mitochondria is impaired and energy production remains reduced, even after reperfusion. UTI contributed to the recovery of cardiac function after reperfusion, probably by reducing the severity of mitochondrial dysfunction during a state of shock and by maintaining energy production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847393     DOI: 10.1097/01.CCM.0000057037.44171.BA

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  Effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy: a randomized trial.

Authors:  Bora Lee; Sook Young Lee; Na Young Kim; Koon Ho Rha; Young Deuk Choi; Sujung Park; So Yeon Kim
Journal:  Surg Endosc       Date:  2017-06-07       Impact factor: 4.584

2.  Urinary trypsin inhibitor attenuates lipopolysaccharide-induced acute lung injury by blocking the activation of p38 mitogen-activated protein kinase.

Authors:  Xinying Zhang; Fengqin Liu; Haiyan Liu; Hongxia Cheng; Wei Wang; Qiang Wen; Yulin Wang
Journal:  Inflamm Res       Date:  2011-01-19       Impact factor: 4.575

3.  Protective effects of tumor necrosis factor alpha antibody and ulinastatin on liver ischemic reperfusion in rats.

Authors:  Yan-Ling Yang; Ji-Peng Li; Xiao-Ping Xu; Ke-Feng Dou; Shu-Qiang Yue; Kai-Zong Li
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

4.  Urinary trypsin inhibitor ameliorates renal tissue oxygenation after ischemic reperfusion in rats.

Authors:  Satoshi Taie; Masaaki Ueki; Kosuke Chujo; Takehiko Asaga; Yasuyuki Iwanaga; Junichiro Ono; Nobuhiro Maekawa
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

5.  Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication.

Authors:  Rehab E Abo El Gheit; Marwa Mohamed Atef; Ghada A Badawi; Walaa M Elwan; H A Alshenawy; Marwa Nagy Emam
Journal:  J Physiol Biochem       Date:  2020-08-14       Impact factor: 4.158

6.  Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation.

Authors:  Dongmei Song; Geng Song; Yinghao Niu; Wei Song; Jiantao Wang; Lei Yu; Jianwang Yang; Xin Lv; Harry Steinberg; Shu Fang Liu; Baoshan Wang
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

7.  Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model.

Authors:  Il-Woo Shin; In-Seok Jang; Seung-Min Lee; Kyeong-Eon Park; Seong-Ho Ok; Ju-Tae Sohn; Heon-Keun Lee; Young-Kyun Chung
Journal:  Korean J Anesthesiol       Date:  2011-12-20

8.  Ulinastatin inhibits cerebral ischemia-induced apoptosis in the hippocampus of gerbils.

Authors:  Young-Sam Cho; Mal-Soon Shin; Il-Gyu Ko; Sung-Eun Kim; Chang-Ju Kim; Yun-Hee Sung; Hye-Sun Yoon; Bong-Jae Lee
Journal:  Mol Med Rep       Date:  2015-04-15       Impact factor: 2.952

9.  Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients.

Authors:  Lingmin Zhang; Ning Wang; Suna Zhou; Wenguang Ye; Qinglin Yao; Guixia Jing; Mingxin Zhang
Journal:  World J Surg Oncol       Date:  2013-04-10       Impact factor: 2.754

10.  Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide.

Authors:  Ken-Ichiro Inoue; Hirohisa Takano; Rie Yanagisawa; Toshikazu Yoshikawa
Journal:  J Clin Biochem Nutr       Date:  2008-10-31       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.